It really was a pleasure conversing with him, the board seemed...

It really was a pleasure conversing with him, the board seemed very friendly...

I got that feeling too.

Well done to those who held for the long term it was frustrating having capital tied up and the company ticking all the right boxes, yet this was being reflected in the share price.

I'm sure some sold out too early out of boredom/frustration/loss. What made me hold was seeing the large holders increasing their stake as evidenced in the company reports. JP Morgan, Sigma and Morgan Stanley all took more from the register between 2016 and 2017.
https://hotcopper.com.au/threads/an...s-appendix-4e.3648732/page-4?post_id=26878167

To groups outside of healthcare, MedAdvisor might be seen as a startup. Even with a great product, roadmap to success and a growing customer and revenue base (pharmacies, big pharma and end users), a fickle market likes to see runs on the board. Today Management hit it of the park. I imagine there are new (high net worth) buyers who will hold looking for more gains from 5 cents.

I'm very confident with my position and believe we have an excellent board to lead us into the future.

Same. The new Exec and international appointments should deliver results very soon.
https://www.medadvisor.com.au/Investors/CorporateDirectory
http://www.asx.com.au//asxpdf/20170912/pdf/43m86gpc388y6q.pdf

Apologies to Rob for my not putting my phone on silent :~

Ha!